NCT00065169
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- UCLA Neuropsychiatric Institute Los Angeles, California, United States
Clinical trial condition
Alzheimer Disease
Explore clinical trials studying Alzheimer Disease. Study availability and eligibility vary by location and protocol.
1,340 public trials
297 recruiting studies
Alzheimer Disease trial results
NCT03757325
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Clinical Site(s) Miami, Florida, United States
- Clinical Site(s) Orlando, Florida, United States
- Clinical Site(s) Dallas, Texas, United States
- Clinical Site(s) Salt Lake City, Utah, United States
NCT04279418
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +10 more
- Locations
-
- Department of Neurolgy, Xuanwu Hospital of Capital Medical University Beijing, Beijing Municipality, China
Completed
A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density
NCT03577262
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- VU Medical Center, Dept. Radiology and Nuclear Medicine Amsterdam, Netherlands
- QPS Netherlands B.V. Groningen, Netherlands
- University Medical Center Groningen, Nuclear Medicine and Molecular Imaging Groningen, Netherlands
Completed
Caregiver Study Dr. Phillips
NCT03653871
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Dr. Phillips Center for the Performing Arts Orlando, Florida, United States
NCT03545789
- Conditions
- Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +19 more
- Locations
-
- Invicro New Haven, Connecticut, United States
NCT00956410
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Novartis Investigative Site Bordeaux, France
- Novartis Investigative Site Stockholm, Sweden
- Novartis Investigative Site Basel, Switzerland
- Novartis Investigative Site Southampton, United Kingdom
Completed
Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
NCT00733863
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Centre Hospitalier Universitaire Pellegrin Bordeaux, France
- Karolinska Universitetssjukhuset Huddinge Stockholm, Sweden
- NeuroPsychologieZentrum Basel, Switzerland
- Moorgreen Hospital Southampton, United Kingdom
Completed
Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease
NCT01707719
- Conditions
- Adrenal Gland Diseases, Adrenocortical Hyperfunction, Alzheimer Disease, +10 more
- Locations
-
- Policlinico Universitario Campus Bio-Medico Rome, RM, Italy
NCT03698695
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
- Locations
-
- CHU Bordeaux Bordeaux, France
- CHU Clermont Ferrand Clermont-Ferrand, France
- CHU Grenoble Grenoble, France
- CHU Lille Lille, France